Eli Lilly
Eli Lilly and Company is an American pharmaceutical company, founded in 1876, that is known for its contributions to the development of various medications across multiple therapeutic areas, including diabetes, oncology, and immunology. The company has gained recognition for its diabetes treatment, Mounjaro, which is part of the GLP-1 receptor agonist class. Eli Lilly is committed to improving patient outcomes through innovative products and has a strong focus on research and development.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 7.00 | 0.06% | +0% | 9,216,900 | 5,958 | $400,000 | 259$ |
| Australia | 1 | 5.00 | 0.06% | +0% | 25,499,884 | 14,580 | $1,380,000 | 789$ |
| Germany | 1 | 3.00 | 0.06% | +0% | 83,783,942 | 51,119 | $3,845,000 | 2,346$ |
| Estonia | 1 | 7.00 | 0.06% | +0% | 1,326,539 | 758 | $31,000 | 18$ |
| Totals | 4 | 119,827,265 | 72,415 | $5,656,000 | 3,412$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Estonia:
Eli Lilly is a competitor that has introduced better products in the weight loss market.
7
Germany:
Eli Lilly is a US pharmaceutical company involved in the pricing controversy of the drug Mounjaro.
3
Israel:
Eli Lilly presented research data showing the effects of Kisunla in Alzheimer's treatment.
7
Australia:
Shares of major manufacturers Eli Lilly, Merck and Pfizer pared earlier gains.
5
Guatemala:
Eli Lilly is the pharmaceutical company that manufactures the orforglipron pill.
6
Switzerland:
Eli Lilly is one of the leading companies in the obesity treatment market.
8
Monaco:
Eli Lilly has submitted a new reimbursement request for their obesity medication and is awaiting a response.
7
United States:
Eli Lilly is the maker of Zepbound, a drug involved in a clinical trial comparing obesity treatments.
6
Romania:
Eli Lilly is a pharmaceutical company that recently presented the results of a phase 3 clinical study regarding Orforglipron, an experimental oral medication for treating type 2 diabetes.
7
Italy:
Eli Lilly announced the results of a Phase 3 study of its pill Orforglipron that could be as effective as popular injectable drugs Mounjaro and Ozempic.
8